EGFR and non-small cell lung carcinoma: The age-standardised incidence rate (ASR) of non-squamous NSCLC was 22.4 cases per 100,000 person-years overall, 5.1 and 17.4 per 100,000 person-years for EGFR-positive and -negative disease, respectively, based on the tested proportions.